We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Integrated immune gene expression signature and molecular classification in gastric cancer: New insights.
- Authors
Refolo, Maria Grazia; Lotesoriere, Claudio; Messa, Caterina; Caruso, Maria Gabriella; D'Alessandro, Rosalba
- Abstract
Gastric cancer (GC) is characterized by extreme heterogeneity due to histopathological differences, molecular characteristics, and immune gene expression signature. Until recently, several targeted therapies failed due to this complexity. The recent immunotherapy resulted in more effective and safe approaches in several malignancies. All tumors could be considered potentially immunogenic and the new knowledge regarding the interactions among tumor cells, immune cells, and tumor microenvironment (TME) allowed to reverse possible immune resistance. The immune response is a complex multisteps process that finely regulates the balance between the recognition of non‐self and the prevention of autoimmunity. Cancer cells can use these pathways to suppress tumor immunity as a major mechanism of immune resistance. The recent molecular classifications of GCs by The Cancer Genome Atlas (TCGA) and by the Asian Cancer Research (ACRG) networks, together with the identification of multiple biomarkers, open new perspectives for stratification of patients who might benefit from a long‐term immune checkpoint therapy. One of the major processes that contribute to an immunosuppressive microenvironment is represented by tumor angiogenesis. The cellular mechanisms inducing both angiogenesis and immunosuppressive responses are often reached by the same cell types and soluble factors, such as vascular endothelial growth factor A (VEGFA). Recent studies point out that combinatorial strategies should be adapted as useful therapeutic approach to reverse the immunosuppressive status of microenvironment occurring in a relevant percentage of gastric tumors.
- Subjects
TUMOR classification; STOMACH cancer; VASCULAR endothelial growth factors; GENE expression; TUMOR microenvironment
- Publication
Journal of Leukocyte Biology, 2020, Vol 108, Issue 2, p633
- ISSN
0741-5400
- Publication type
Article
- DOI
10.1002/JLB.4MR0120-221R